Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stressed related mucosal disease.
Tsai
Jai-Jen
JJ
Lin
Hwai-Jeng
HJ
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D002927:Cimetidine / Q000008:administration & dosage*; D016638:Critical Illness; D005753:Gastric Mucosa / Q000187:drug effects*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control; D006801:Humans; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D000077402:Pantoprazole; D013272:Stomach Diseases / Q000517:prevention & control*; D013312:Stress, Physiological
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D002927:Cimetidine; D000077402:Pantoprazole